Hyperzincuria is a common feature in diabetic patients, which is still not
understood. Based on the above consideration, the aim of the present study
was to investigate the renal handling of zinc in insulin-dependent diabetes
mellitus (IDDM) patients. The glomerular filtration rate, urinary zinc exc
retion, zinc clearance, zinc clearance/creatinine clearance ratio, zinc tub
ular reabsorption, glycosuria, plasma glucose, C-peptide, glucagon, and cor
tisol were investigated in 10 normal individuals (Group C1 and Group C2, re
spectively) and 10 IDDM patients (Group E1: hyperglycemic and glycosuric an
d Group E2: normoglycemic and aglycosuric) during placebo or venous zinc to
lerance test. The results showed that urinary zinc excretion and renal zinc
clearance were increased after zinc injection in normal individuals (Group
C2) and IDDM patients (Groups E1 and E2) when compared with normal individ
uals-placebo (Group C1). However, these renal parameters were statistically
more significant in the hyperglycemic and glycosuric diabetics (Group E1).
Because patients in Group E1 had the lowest plasma C-peptide levels and sh
owed a strong negative correlation between CZn++/Ccr ratio and this hormone
, we suggest that in this setting insulin inhibits urinary zinc excretion.